CAMBRIDGE, Mass., March 10 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the Cowen & Company 28th Annual Healthcare Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.
The presentation will include an update on VELCADE(R) (bortezomib) for Injection and product candidates in the development pipeline. The presentation will be delivered at 2:30 p.m. ET on Monday, March 17, 2008 from the Boston Marriot Copley Place Hotel in Boston, MA. The presentation will be archived for 30 days.
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.
|SOURCE Millennium Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved